Breaking News - The Fly

Open Search

GANX

Gain Therapeutics

$

()

Gain Therapeutics appoints Gene Mack as CFO

GANX

4/8/2024 - 09:28am

Gain Therapeutics appoints Jonas Hannestad as CMO

GANX

4/1/2024 - 09:26am

Gain Therapeutics reports FY23 EPS ($1.71), consensus ($1.57)

GANX

3/26/2024 - 08:04am

Gain Therapeutics presents data at AD/PD 2024 conference

GANX

3/5/2024 - 08:09am

Gain Therapeutics to host research and development day

GANX

2/22/2024 - 10:32am

Gain Therapeutics announces preclinical data on GT-02287

GANX

2/6/2024 - 08:12am

Gain Therapeutics issues letter to shareholders

GANX

1/31/2024 - 08:05am

Gain Therapeutics files to sell 744,026 shares of common stock for holders

GANX

12/19/2023 - 16:53pm

Gain Therapeutics price target lowered to $9 from $10 at H.C. Wainwright

GANX

12/4/2023 - 06:12am

Gain Therapeutics announces preclinical data on class of allosteric regulators

GANX

12/1/2023 - 08:08am

Gain Therapeutics prices 2.2M shares at $2.005 in public offering

GANX

11/21/2023 - 08:58am

Fly Intel: After-Hours Movers

SYM , FEIM , MOR

…

11/20/2023 - 20:28pm

Gain Therapeutics files to sell common stock, no amount given

GANX

11/20/2023 - 16:04pm

Gain Therapeutics reports Q3 EPS (37c), consensus (45c)

GANX

11/14/2023 - 07:14am

Gain announces dosing of first two subjects in Phase 1 trial of GT-02287

GANX

10/4/2023 - 07:01am